NAA20
Basic information
Region (hg38): 20:20017310-20033655
Previous symbols: [ "NAT5" ]
Links
Phenotypes
GenCC
Source:
- intellectual developmental disorder, autosomal recessive 73 (Limited), mode of inheritance: AR
- intellectual developmental disorder, autosomal recessive 73 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, autosomal recessive 73 | AR | Cardiovascular | Among other findings, the condition can include congenital cardiac anomalies, and awareness may allow early intervention and management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic | 34230638 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAA20 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 7 | 0 | 0 |
Variants in NAA20
This is a list of pathogenic ClinVar variants found in the NAA20 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-20017412-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
20-20025758-A-G | Intellectual developmental disorder, autosomal recessive 73 | Likely pathogenic (Mar 17, 2024) | ||
20-20026805-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
20-20026853-C-T | Intellectual developmental disorder, autosomal recessive 73 | Pathogenic (Jan 27, 2022) | ||
20-20026871-T-C | not specified | Uncertain significance (Feb 03, 2022) | ||
20-20026904-A-T | not specified | Uncertain significance (Nov 09, 2021) | ||
20-20032542-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
20-20032605-A-G | not specified | Uncertain significance (Sep 22, 2023) | ||
20-20033125-G-A | not specified | Uncertain significance (Dec 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAA20 | protein_coding | protein_coding | ENST00000334982 | 6 | 16540 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00620 | 0.916 | 125717 | 0 | 31 | 125748 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.31 | 65 | 102 | 0.635 | 0.00000523 | 1160 |
Missense in Polyphen | 10 | 24.966 | 0.40055 | 287 | ||
Synonymous | -0.552 | 42 | 37.7 | 1.11 | 0.00000225 | 334 |
Loss of Function | 1.52 | 5 | 10.2 | 0.488 | 4.97e-7 | 129 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000350 | 0.000337 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000693 | 0.000693 |
European (Non-Finnish) | 0.0000803 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic subunit of the NatB complex which catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Asp, Met-Glu, Met-Asn and Met-Gln. Proteins with cell cycle functions are overrepresented in the pool of NatB substrates. Required for maintaining the structure and function of actomyosin fibers and for proper cellular migration. {ECO:0000269|PubMed:18570629}.;
- Pathway
- Metapathway biotransformation Phase I and II
(Consensus)
Recessive Scores
- pRec
- 0.0948
Intolerance Scores
- loftool
- 0.798
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.141
- hipred
- N
- hipred_score
- 0.351
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.730
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Low | Medium |
Mouse Genome Informatics
- Gene name
- Naa20
- Phenotype
Gene ontology
- Biological process
- N-terminal peptidyl-methionine acetylation
- Cellular component
- nucleus;cytoplasm;cytosol;NatB complex
- Molecular function
- peptide alpha-N-acetyltransferase activity